Updates in the Management of Head and Neck
Marshall R. Posner, MD, Medical Director, Head and Neck Oncology Program, Dana-Farber Cancer Institute.
With Comments by David Raben, MD, University of Colorado Health Sciences Center. July 2008.

Proteomics: The Next Revolution in Prostate Cancer Diagnostics
Rob Getzenberg, PhD, University of Pittsburgh Cancer Institute. January 2008.

New Agents for the Treatment of Lymphoma: A Review of the Literature
Fredrick B. Hagemeister, MD, The Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
With Comments by John P. Leonard, MD, Associate Professor of Medicine, Weill Medical College of Cornell University; Clinical Director, New York-Cornell Center for Lymphoma and Myeloma in New York City. January 1, 2008

Case Study in Refractory Anemia
Ravi Vij, MD - Washingtion University in St. Louis School of Medicine. Release Date: February 1, 2007.

Case Study in Refractory Anemia with Excess Blasts
Ravi Vij, MD - Washingtion University in St. Louis School of Medicine. Release Date: February 1, 2007.

Case Study in Refractory Anemia with Excess Blasts in Transformation
Ravi Vij, MD - Washingtion University in St. Louis School of Medicine. Release Date: February 1, 2007.

Management Approaches in Head and Neck Cancer
David Raben, MD - University of Colorado Health Sciences Center. January 1, 2008.

Status of Computerized Tomographic Colonoscopy (CTC)
John Klock, MD, co-founder and Chairman Holistica Hawaii; and C. Dean Buckner, MD, founding member Fred Hutchinson Cancer Research Center. January 1, 2008.

Strategies for Treatment of Chemotherapy-Induced Nausea and Vomiting
Steven M. Grunberg, MD - University of Vermont College of Medicine. January 1, 2008.

Pre-Clinical and Clinical Issues Regarding Head and Neck Cancer
David Raben, MD - University of Colorado Health Sciences Center. September 19, 2006.

Treatment Strategies for Colorectal Cancer
Leonard B. Saltz MD - Professor of Medicine, Weill Medical College of Cornell University. September 19, 2006.

Advances in the Treatment of Myelosuppression and Anemia
John Glaspy, MD, Director of Clinical Research Unit Shared Resource, UCLA Medical Center. September 19, 2006.

Biomarkers and Adjuvant Treatment Planning Strategies for Patients with a Node-Negative, Estrogen Receptor-Positive Breast Cancer
David M. Hyams, MD, FACS and Ruth Oratz, MD, FACP. July 2006.

Classifying and Managing Chemotherapy-Induced Anemia
Charles H. Weaver, MD, and Jenny Maxon, RN. July 2006.

Diagnostic Imaging Update: Soft Tissue Sarcomas
By Edson L. Knapp, MD; Mark J. Kransdorf, MD; G. Douglas Letson, MD. February 2005.

Retroperitoneal Sarcomas
By T. Christopher Windham, MD; Peter W. T. Pisters, MD. February 2005.

Advanced-Technology Radiation Therapy in the Management of Bone and Soft Tissue Sarcomas
By Thomas F. DeLaney, MD; Alexei V. Trofimov, PhD; Martijn Engelsman, PhD; Herman D. Suit, MD, DPhil. February 2005.

Limb Salvage Management of Pathologic Fractures of Primary Malignant Bone Tumors
By Walid Ebeid, MD; Sherif Amin, MD; Amr Abdelmegid, MD. February 2005.

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
By William I. Bensinger, MD. June 2006.

Molecularly Targeted Therapies for Breast Cancer
By Timothy J. Hobday, MD; Edith A. Perez, MD. April 2005.

Targeted Therapy in Multiple Myeloma
By Wee Joo Chng, MD; Lee Gong Lau, MD; Noorainun Yusof, MD; Benjamin M. F. Mow, MD. April 2005.

Targeted Therapies in the Treatment of Colorectal Cancers
By Todd Alekshun, MD, Chris Garrett, MD. April 2005.

Small Molecule & Monoclonal Antibody Therapies in Neurooncology
By Nicholas Butowski, MD, Susan M. Chang, MD. October 2005.

Sentinel Node Biopsy for Thin Melanomas: Which Patients Should Be Considered?
By Christopher A. Puleo, PA-C; Jane L. Messina, MD; Adam I. Riker, MD; L. Frank Glass, MD; Christopher Nelson, MD; C. Wayne Cruse, MD; Timothy M. Johnson, MD; Vernon K. Sondak, MD. October 2005.

Review of Fluorine-18-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in the Follow-Up of Medullary and Anaplastic Thyroid Carcinomas
By Nasim Khan, MD, PhD; Noboru Oriuchi, MD, PhD; Tetsuya Higuchi, MD, PhD; Keigo Endo, MD, PhD. October 2005.

Enhanced Detection of Hepatocellular Carcinoma
By Motawa E. El-Houseini, PhD, Mohammed S. Mohammed, PhD, Wael M. Elshemey, PhD, Tarek D. Hussein, PhD, Omar S. Desouky, PhD, and Anwar A. Elsayed, PhD. October 2005.

Head and Neck Melanoma
By David H. Lawson, MD. October 2005.

Choices in Adjuvant Therapy for Melanoma
By David H. Lawson, MD. October 2005.

Chemoprevention of Melanoma: Theoretical and Practical Considerations
By Marie-France Demierre, MD, FRCPC, Vernon K. Sondak, MD. October 2005.

Cutaneous Melanoma: Prognostic Factors
By Jade Homsi, MD, Mohammed Kashani-Sabet, MD, Jane L. Messina, MD, Adil Daud, MD. October 2005.

Treating Malignant Disease With Reduced Intensity Stem Cell Transplants - A Review
By C. Dean Buckner, MD. December 2005.

Rethinking Allogeneic Stem Cell Transplants for Chronic Myeloid Leukemia in the Gleevec® Era
By C. D. Buckner, MD. November 2005.

Allogeneic Stem Cell Transplantation for Multiple Myeloma
By William I. Bensinger, MD, Professor, University of Washington; Member, Fred Hutchinson Cancer Research Center. November 2005.

Advances in the Prevention and Management of Oral Mucositis
By Jenny Maxon, RN. January 2007.

Medical Genomics: Implications for Clinical Oncology
By Charles H. Weaver, MD, and Dayna Deuter. January 2005.

The Role of Erythropoietic Agents in Managing the Anemia of Cancer
By Robert E. Smith, Jr., MD, South Carolina Oncology Associates, PA. January 2005.

Antisense Therapy: An Overview
By Jenny Maxon, RN and Charles H. Weaver, MD. January 2005.